Das Krankenhaus Bethanien Moers ist eine im nordrhein-westfälischen Moers am westlichen Rand des Ruhrgebietes ansässige Klinik. Träger ist die Stiftung Krankenhaus Bethanien für die Grafschaft Moers. Das Krankenhaus verfügt über 510 Betten und beschäftigt rund 1800 Mitarbeiter.

During the past decade, Krankenhaus Bethanien conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Krankenhaus Bethanien" #1 sponsor was "ResMed" with 3 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Heinrich-Heine University, Duesseldorf" with 1 trials sponsored and "Radboud University Medical Center" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenhaus Bethanien" #1 collaborator was "CRI-The Clinical Research Institute GmbH" with 1 trials as a collaborator and "INTERREG V-A" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Krankenhaus Bethanien" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "Heart Failure" (2 trials), "Breast Cancer" (1 trials), "Cardiovascular Diseases" (1 trials) and "Cardiovascular Risk Factor" (1 trials). Many other conditions were trialed in "Krankenhaus Bethanien" in a lesser frequency.

Most popular intervention types in "Krankenhaus Bethanien" are "Drug" (4 trials), "Device" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amivantamab" (2 trials), "Carboplatin" (2 trials), "Pemetrexed" (2 trials), "AMG 510" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Krankenhaus Bethanien" are 6 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Krankenhaus Bethanien". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Krankenhaus Bethanien, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Krankenhaus Bethanien, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".